HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Argani Selected Research

Transcription Factors (Transcription Factor)

8/2009Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.
1/2001The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
11/2000Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.
9/2000Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Argani Research Topics

Disease

14Neoplasms (Cancer)
08/2009 - 01/2000
4Carcinoma (Carcinomatosis)
08/2009 - 11/2000
4Adenocarcinoma
12/2001 - 09/2000
2Renal Cell Carcinoma (Grawitz Tumor)
08/2009 - 01/2001
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2001 - 06/2001
2Fibrosarcoma
11/2001 - 01/2000
2Synovial Sarcoma (Synovioma)
08/2000 - 02/2000
1Kidney Neoplasms (Kidney Cancer)
08/2009
1Mesothelioma
12/2001
1Ovarian Neoplasms (Ovarian Cancer)
12/2001
1Carcinogenesis
02/2001
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
02/2001
1Colorectal Neoplasms (Colorectal Cancer)
02/2001
1Microsatellite Instability
02/2001
1Sarcoma (Soft Tissue Sarcoma)
01/2001
1Alveolar Soft Part Sarcoma
01/2001
1Neoplasms, Cystic, Mucinous, and Serous
11/2000
1Carcinoma in Situ
11/2000
1Pancreatic Intraductal Neoplasms
09/2000
1Cysts
08/2000
1Clear Cell Sarcoma
07/2000
1Wilms Tumor (Wilm's Tumor)
01/2000
1Melanoma (Melanoma, Malignant)
01/2000
1Mesoblastic Nephroma (Congenital Mesoblastic Nephroma)
01/2000
1Primitive Neuroectodermal Tumors (PNET)
01/2000
1Necrosis
01/2000

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
08/2009 - 09/2000
4Transcription Factors (Transcription Factor)IBA
08/2009 - 09/2000
4ParaffinIBA
11/2001 - 01/2000
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2001 - 01/2000
4Keratins (Keratin)IBA
07/2001 - 01/2000
3RNA (Ribonucleic Acid)IBA
08/2000 - 01/2000
2Transforming Growth Factor beta (TGF-beta)IBA
09/2006 - 02/2001
2Tumor Biomarkers (Tumor Markers)IBA
12/2001 - 06/2001
2Messenger RNA (mRNA)IBA
12/2001 - 06/2001
2Mucin-1 (CA 15-3 Antigen)IBA
07/2001 - 05/2001
1Cathepsin KIBA
08/2009
1Microphthalmia-Associated Transcription FactorIBA
08/2009
1Polytetrafluoroethylene (Teflon)FDA Link
08/2009
1CarcinogensIBA
09/2006
1MesothelinIBA
12/2001
1beta CateninIBA
07/2001
1MART-1 AntigenIBA
06/2001
1Trefoil Factor-2IBA
06/2001
1LipocalinsIBA
06/2001
1AntigensIBA
06/2001
1AgglutininsIBA
05/2001
1Keratin-7 (Cytokeratin 7)IBA
05/2001
1Transforming Growth Factor-beta Type II ReceptorIBA
02/2001
1LigandsIBA
02/2001
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
02/2001
1DNA (Deoxyribonucleic Acid)IBA
01/2001
1Monoclonal AntibodiesIBA
11/2000
1VimentinIBA
08/2000
1DesminIBA
08/2000
1Formaldehyde (Formol)FDA Link
01/2000
1AntibodiesIBA
01/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2000
1S100 Proteins (S 100 Protein)IBA
01/2000

Therapy/Procedure

2Therapeutics
09/2006 - 04/2001
1Prostatectomy (Retropubic Prostatectomy)
12/2001
1Biological Therapy
02/2001
1Adjuvant Chemotherapy
07/2000